Global Targeted Sequencing Market Size is valued at USD 3.9 Bn in 2024 and is predicted to reach USD 14.7 Bn by the year 2034 at a 14.4% CAGR during the forecast period for 2025-2034.
Key Industry Insights & Findings from the Report:
A specific group of genes or genome regions are identified and sequenced in the process known as targeted sequencing. Researchers are able to focus their time, resources, and data analysis on specific areas of interest due to targeted sequencing, which also allows sequencing at significantly higher coverage levels. A large range of targeted sequencing library prep kits are available, including kits with probe sets centered on specific fields of interest such as cancer, cardiomyopathy, or autism.
Expansion of genome mapping initiatives, the expansion of next-generation sequencing (NGS) applications, rising healthcare costs, and technological advancements in sequencing platforms are all causing the targeted sequencing market development during the forecast period. Furthermore, major companies all over the globe have strengthened their R&D capacities. This heavy emphasis on COVID-19 vaccine research provided a lucrative opportunity for NGS adoption throughout the pandemic period. For example, a group of Chinese researchers used the Oxford Nanopore Technologies (U.K.) product MinION Mk1C to sequence COVID-19 samples.
However, the lack of skilled professionals and ethical and regulatory restrictions related to targeted sequencing technology are anticipated to hinder market development over the projection period.
The targeted sequencing market is segmented on the basis of product type, target enrichment method, type of target capture, application, and end-user. On the basis of product type, the market is segregated into instruments, kits/panels and assays, services, and other product types. By target enrichment method, the market is segmented into hybridization capture, amplicon sequencing, and other Target Enrichment Methods.
The target capture segments include targeted DNA sequencing, targeted RNA sequencing, and other types of target capture. By application, the market is segmented into oncology, reproductive health, hereditary diseases, neurological disorders, infectious diseases, cardiovascular diseases, rare diseases, and other applications. The end-user segment includes diagnostic and clinical laboratories, academic and research institutions, pharmaceutical & biotech companies, and other end users.
The oncology category is expected to hold a major share of the global Targeted Sequencing Market in 2024. This is attributed to the number of diagnostic methods, and cancer treatment rates are growing along with the frequency of the disease. 18.1 million new cases of cancer were recorded in 2018, and the International Agency for Research on Cancer (IARC) of the World Health Organization (WHO) predicts that the number will rise to 24.1 million cases by 2030 and 29.5 million new cases by 2040. Therefore, there is a growing market for next-generation sequencing technologies due to the increasing need for cancer therapy, related medications, and genetic analysis techniques to find anomalies in gene expression and function.
The diagnostic and clinical laboratories segment is projected to boost at a rapid rate in the global targeted sequencing market. Due to their easy accessibility, a growing number of cancer patients are visiting diagnostic labs for diagnosis and treatment, propelling the next-generation sequencing market for this end-user sector. The development of the next-generation sequencing market for clinical diagnostic laboratories is also supported by improvements in healthcare infrastructure in both developed and developing countries.
The North America Targeted Sequencing Market is expected to register the highest market share in terms of revenue in the near future. With the COVID-19 epidemic in the area, targeted sequencing technology is becoming more and more common as a standard clinical diagnostic test. For instance, the United States (U.S.) Food and Drug Administration received Breakthrough Device Designation for Pathogenomix Inc.'s Patho-Seq assay in January 2022. This firm specializes in next-generation sequencing pathogen diagnostics (FDA). Moreover, the Asia-Pacific region is anticipated to grow at the fastest rate over the projection period owing to the region's rapid economic development, rising cancer incidence, and increased government attention to the improvement of the healthcare sector.
Other prominent growth drivers of the Asia-Pacific next-generation sequencing market include government initiatives and funding for extensive genome sequencing studies to develop targeted medications.
| Report Attribute | Specifications |
| Market size value in 2024 | USD 3.9 Bn |
| Revenue forecast in 2034 | USD 14.7 Bn |
| Growth rate CAGR | CAGR of 14.4% from 2025 to 2034 |
| Quantitative units | Representation of revenue in US$ Billion, and CAGR from 2025 to 2034 |
| Historic Year | 2021 to 2024 |
| Forecast Year | 2025-2034 |
| Report coverage | The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends |
| Segments covered | Product Type, Target Enrichment Method, Type Of Target Capture, Application, And End-User |
| Regional scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia |
| Competitive Landscape | Agilent Technologies, Inc., Azenta US, Inc. (GENEWIZ), BGI Group (MGI Tech Co., Ltd.), CD Genomics, Daicel Corporation (Daicel Arbor Biosciences), Danaher. (Integrated DNA Technologies, Inc.), F. Hoffmann-La Roche Ltd, Illumina, Inc., LGC Limited (LGC Biosearch Technologies), PacBio., PerkinElmer Inc., Psomagen, QIAGEN N.V., Takara Bio Inc., Tecan Trading AG, Thermo Fisher Scientific Inc., Twist Bioscience. |
| Customization scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing and available payment methods | Explore pricing alternatives that are customized to your particular study requirements. |
Targeted Sequencing Market By Product Type-
Targeted Sequencing Market By Target Enrichment Method-
Targeted Sequencing Market By Type of Target Capture -
Targeted Sequencing Market By Application-
Targeted Sequencing Market By End-User-
Targeted Sequencing Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Targeted Sequencing Market Snapshot
Chapter 4. Global Targeted Sequencing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Product Type Estimates & Trend Analysis
5.1. by Product Type & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Product Type:
5.2.1. Instruments
5.2.2. Kits/Panels and Assays
5.2.3. Services
5.2.4. Other Product Types
Chapter 6. Market Segmentation 2: by Target Enrichment Method Estimates & Trend Analysis
6.1. by Target Enrichment Method & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Target Enrichment Method:
6.2.1. Hybridization Capture
6.2.2. Amplicon Sequencing
6.2.3. Other Target Enrichment Methods
Chapter 7. Market Segmentation 3: by Type of Target Capture Estimates & Trend Analysis
7.1. by Type of Target Capture & Market Share, 2024 & 2034
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Type of Target Capture:
7.2.1. Targeted DNA Sequencing
7.2.1.1. Targeted Methyl Sequencing
7.2.2. Targeted RNA Sequencing
7.2.2.1. Targeted Metagenomic Sequencing
7.2.3. Other Types of Target Capture
Chapter 8. Market Segmentation 4: by Application Estimates & Trend Analysis
8.1. by Application & Market Share, 2024 & 2034
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Application:
8.2.1. Oncology
8.2.1.1. Solid Tumor
8.2.1.2. Liquid Biopsy
8.2.1.3. Minimal Residual Disease Testing
8.2.1.4. Circulating Tumor Cell (CTC) Analysis
8.2.2. Infectious Diseases
8.2.3. Cardiovascular Diseases
8.2.4. Reproductive Health
8.2.4.1. Carrier Screening
8.2.4.2. Non-Invasive Prenatal Testing
8.2.4.3. Preimplantation Genetic Diagnosis (PGD)
8.2.4.4. Newborn Screening
8.2.5. Rare Diseases
8.2.6. Neurological Disorders
8.2.7. Hereditary Diseases
8.2.8. Other Applications
Chapter 9. Market Segmentation 5: by End-User Estimates & Trend Analysis
9.1. by End-User & Market Share, 2024 & 2034
9.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by End-User:
9.2.1. Diagnostic and Clinical Laboratories
9.2.2. Academic and Research Institutions
9.2.3. Pharmaceutical and Biotech Companies
9.2.4. Other End Users
Chapter 10. Targeted Sequencing Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. North America
10.1.1. North America Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
10.1.2. North America Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Target Enrichment Method, 2021-2034
10.1.3. North America Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Type of Target Capture, 2021-2034
10.1.4. North America Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.1.5. North America Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
10.1.6. North America Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
10.2. Europe
10.2.1. Europe Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
10.2.2. Europe Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Target Enrichment Method, 2021-2034
10.2.3. Europe Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Type of Target Capture, 2021-2034
10.2.4. Europe Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.2.5. Europe Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
10.2.6. Europe Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
10.3. Asia Pacific
10.3.1. Asia Pacific Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
10.3.2. Asia Pacific Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Target Enrichment Method, 2021-2034
10.3.3. Asia-Pacific Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Type of Target Capture, 2021-2034
10.3.4. Asia Pacific Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.3.5. Asia Pacific Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
10.3.6. Asia Pacific Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
10.4. Latin America
10.4.1. Latin America Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
10.4.2. Latin America Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Target Enrichment Method, 2021-2034
10.4.3. Latin America Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Type of Target Capture, 2021-2034
10.4.4. Latin America Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.4.5. Latin America Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
10.4.6. Latin America Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
10.5. Middle East & Africa
10.5.1. Middle East & Africa Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
10.5.2. Middle East & Africa Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Target Enrichment Method, 2021-2034
10.5.3. Middle East & Africa Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Type of Target Capture, 2021-2034
10.5.4. Middle East & Africa Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.5.5. Middle East & Africa Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
10.5.6. Middle East & Africa Targeted Sequencing Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Agilent Technologies, Inc.
11.2.2. Azenta US, Inc. (GENEWIZ)
11.2.3. BGI Group (MGI Tech Co., Ltd.)
11.2.4. CD Genomics
11.2.5. Daicel Corporation (Daicel Arbor Biosciences)
11.2.6. Danaher. (Integrated DNA Technologies, Inc.)
11.2.7. F. Hoffmann-La Roche Ltd
11.2.8. Illumina, Inc.
11.2.9. LGC Limited (LGC Biosearch Technologies)
11.2.10. PacBio.
11.2.11. PerkinElmer Inc.
11.2.12. Psomagen
11.2.13. QIAGEN N.V.
11.2.14. Takara Bio Inc.
11.2.15. Tecan Trading AG
11.2.16. Thermo Fisher Scientific Inc.
11.2.17. Twist Bioscience
11.2.18. Other Prominent Players